Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - fosinopril sodium,hydrochlorothiazide -

United States - English - NLM (National Library of Medicine)

rising health, llc - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium 10 mg - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration . ) in using fosinopril sodium and hydrochlorothiazide, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis ).  ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients  (see warnings: head and neck angioedema   and intestinal  angioedema ). fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium 10 mg - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration.) in using fosinopril sodium and hydrochlorothiazide tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis). ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings: head and neck angioedema and intestinal angioedema: ). fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide tablets are also contraindicated in patients who are hypersensitive to fosinopril, to

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium 10 mg - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration . ) in using fosinopril sodium and hydrochlorothiazide, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis ).  ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients  (see warnings:  head and neck angioedema   and intestinal angioedema ). fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any other ace inhibitor, to hydrochlorothiazide, or other sulfonamide-derived drugs, or any other ingredient or component in the formulation. hypersensitivity reactions are more likely to occur in patients with a history of allergy or bronchial asthma.

United States - English - NLM (National Library of Medicine)

ranbaxy pharmaceuticals inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium 10 mg - fosinopril sodium and hydrochlorothiazide tablets, usp is indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration .) in using fosinopril sodium and hydrochlorothiazide tablets, usp, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis ). ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings: head and neck angioedema and intestinal angioedema ). fosinopril sodium and hydrochlorothiazide is contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any othe

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium 10 mg - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy (see dosage and administration). in using fosinopril sodium and hydrochlorothiazide, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis). ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings: head and neck angioedema and intestinal angioedema). fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any other ace inhibi

United States - English - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium 10 mg - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration) in using fosinopril sodium and hydrochlorothiazide tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis). ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings: head and neck angioedema and intestinal angioedema). fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide tablets are also contraindicated in patients who are hypersensitive to fosinopril, to any

United States - English - NLM (National Library of Medicine)

andrx pharmaceuticals, inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinopril - unii:r43d2573wo), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - tablet - 10 mg - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration .) in using fosinopril sodium-hydrochlorothiazide tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis ). ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings: head and neck angioedema and intestinal angiodema .) fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide tablets is also contraindicated in patients who are hypersensitive to fosinopril, to any

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium 10 mg - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration . ) in using fosinopril sodium and hydrochlorothiazide, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis ).  ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients  (see warnings: head and neck angioedema   and intestinal  angioedema ). fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any

United States - English - NLM (National Library of Medicine)

cipla usa inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. these fixed dose combinations are not indicated for initial therapy. (see dosage and administration) in using fosinopril sodium and hydrochlorothiazide tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril does not have a similar risk (see warnings: neutropenia/agranulocytosis). ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings: head and neck angioedema and intestinal angioedema). fosinopril sodium and hydrochlorothiazide tablets are contraindicated in patients who are anuric. fosinopril sodium and hydrochlorothiazide tablets are also contraindicated in patients who are hypersensitive to fosinopril, to any